A pitvarfibrilláció kezelésének nem farmakológiai lehetóségei.

Translated title of the contribution: Non-pharmacologic treatment of atrial fibrillation

Zoltán Csanádi, Tamás Fazekas, A. Varró

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The authors provide an update on non-pharmacological treatment of atrial fibrillation (AF). They emphasize that although antiarrhythmic drugs continue to be first-line therapy for the arrhythmia considered to be a cardiovascular epidemic, clinical research to develop non-pharmacological means of treatment has been unprecedentally intensified during the last decade. Electrical cardioversion is the most successful non-pharmacological method to restore sinus rhythm, also the efficacy and safety of AV node ablation for palliative ventricular rate-controll is established. "Hybrid" therapeutic procedures, involving combinations of pharmacological and non-pharmacological interventions have gained widespread use. Curative transcatheter ablation for arrhythmia prevention is to be considered in case of clinical suggestions that AF is initiated by a primary regular arrhythmia that is amenable to routine catheter ablation (secondary AF). Despite encouraging results, at this point in time, curative catheter ablation for primary AF may offer significant improvement or even cure only for a small subset of patients, mostly young individuals with normal heart, and paroxysmal AF with frequent, symptomatic episodes refractory to multiple antiarrhythmic drugs. These interventions are to be performed in the settings of a clinical research project in some institutions. Regarding pacemaker therapy in case of bradycardia indication, physiologic pacing (AAI or DDD) is associated with significantly lower incidence of atrial fibrillation than ventricular pacing. Large-scale randomized controlled trials are needed to assess the clinical value of specially designed implantable devices to prevent atrial fibrillation in patients with no conventional bradycardia indication. Also, technical optimization and proper clinical evaluation is needed for implantable atrioverters and implantable cardioverter defibrillators capable of atrial cardioversion therapy.

Original languageHungarian
Pages (from-to)1279-1289
Number of pages11
JournalOrvosi Hetilap
Volume144
Issue number26
Publication statusPublished - Jun 29 2003

Fingerprint

Atrial Fibrillation
Cardiac Arrhythmias
Electric Countershock
Catheter Ablation
Anti-Arrhythmia Agents
Bradycardia
Therapeutics
Dichlorodiphenyldichloroethane
Atrioventricular Node
Implantable Defibrillators
Research
Randomized Controlled Trials
Pharmacology
Safety
Equipment and Supplies
Incidence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A pitvarfibrilláció kezelésének nem farmakológiai lehetóségei. / Csanádi, Zoltán; Fazekas, Tamás; Varró, A.

In: Orvosi Hetilap, Vol. 144, No. 26, 29.06.2003, p. 1279-1289.

Research output: Contribution to journalArticle

Csanádi, Z, Fazekas, T & Varró, A 2003, 'A pitvarfibrilláció kezelésének nem farmakológiai lehetóségei.', Orvosi Hetilap, vol. 144, no. 26, pp. 1279-1289.
Csanádi, Zoltán ; Fazekas, Tamás ; Varró, A. / A pitvarfibrilláció kezelésének nem farmakológiai lehetóségei. In: Orvosi Hetilap. 2003 ; Vol. 144, No. 26. pp. 1279-1289.
@article{cdff86a3b58045d9be9ab48f7a065cac,
title = "A pitvarfibrill{\'a}ci{\'o} kezel{\'e}s{\'e}nek nem farmakol{\'o}giai lehet{\'o}s{\'e}gei.",
abstract = "The authors provide an update on non-pharmacological treatment of atrial fibrillation (AF). They emphasize that although antiarrhythmic drugs continue to be first-line therapy for the arrhythmia considered to be a cardiovascular epidemic, clinical research to develop non-pharmacological means of treatment has been unprecedentally intensified during the last decade. Electrical cardioversion is the most successful non-pharmacological method to restore sinus rhythm, also the efficacy and safety of AV node ablation for palliative ventricular rate-controll is established. {"}Hybrid{"} therapeutic procedures, involving combinations of pharmacological and non-pharmacological interventions have gained widespread use. Curative transcatheter ablation for arrhythmia prevention is to be considered in case of clinical suggestions that AF is initiated by a primary regular arrhythmia that is amenable to routine catheter ablation (secondary AF). Despite encouraging results, at this point in time, curative catheter ablation for primary AF may offer significant improvement or even cure only for a small subset of patients, mostly young individuals with normal heart, and paroxysmal AF with frequent, symptomatic episodes refractory to multiple antiarrhythmic drugs. These interventions are to be performed in the settings of a clinical research project in some institutions. Regarding pacemaker therapy in case of bradycardia indication, physiologic pacing (AAI or DDD) is associated with significantly lower incidence of atrial fibrillation than ventricular pacing. Large-scale randomized controlled trials are needed to assess the clinical value of specially designed implantable devices to prevent atrial fibrillation in patients with no conventional bradycardia indication. Also, technical optimization and proper clinical evaluation is needed for implantable atrioverters and implantable cardioverter defibrillators capable of atrial cardioversion therapy.",
author = "Zolt{\'a}n Csan{\'a}di and Tam{\'a}s Fazekas and A. Varr{\'o}",
year = "2003",
month = "6",
day = "29",
language = "Hungarian",
volume = "144",
pages = "1279--1289",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "26",

}

TY - JOUR

T1 - A pitvarfibrilláció kezelésének nem farmakológiai lehetóségei.

AU - Csanádi, Zoltán

AU - Fazekas, Tamás

AU - Varró, A.

PY - 2003/6/29

Y1 - 2003/6/29

N2 - The authors provide an update on non-pharmacological treatment of atrial fibrillation (AF). They emphasize that although antiarrhythmic drugs continue to be first-line therapy for the arrhythmia considered to be a cardiovascular epidemic, clinical research to develop non-pharmacological means of treatment has been unprecedentally intensified during the last decade. Electrical cardioversion is the most successful non-pharmacological method to restore sinus rhythm, also the efficacy and safety of AV node ablation for palliative ventricular rate-controll is established. "Hybrid" therapeutic procedures, involving combinations of pharmacological and non-pharmacological interventions have gained widespread use. Curative transcatheter ablation for arrhythmia prevention is to be considered in case of clinical suggestions that AF is initiated by a primary regular arrhythmia that is amenable to routine catheter ablation (secondary AF). Despite encouraging results, at this point in time, curative catheter ablation for primary AF may offer significant improvement or even cure only for a small subset of patients, mostly young individuals with normal heart, and paroxysmal AF with frequent, symptomatic episodes refractory to multiple antiarrhythmic drugs. These interventions are to be performed in the settings of a clinical research project in some institutions. Regarding pacemaker therapy in case of bradycardia indication, physiologic pacing (AAI or DDD) is associated with significantly lower incidence of atrial fibrillation than ventricular pacing. Large-scale randomized controlled trials are needed to assess the clinical value of specially designed implantable devices to prevent atrial fibrillation in patients with no conventional bradycardia indication. Also, technical optimization and proper clinical evaluation is needed for implantable atrioverters and implantable cardioverter defibrillators capable of atrial cardioversion therapy.

AB - The authors provide an update on non-pharmacological treatment of atrial fibrillation (AF). They emphasize that although antiarrhythmic drugs continue to be first-line therapy for the arrhythmia considered to be a cardiovascular epidemic, clinical research to develop non-pharmacological means of treatment has been unprecedentally intensified during the last decade. Electrical cardioversion is the most successful non-pharmacological method to restore sinus rhythm, also the efficacy and safety of AV node ablation for palliative ventricular rate-controll is established. "Hybrid" therapeutic procedures, involving combinations of pharmacological and non-pharmacological interventions have gained widespread use. Curative transcatheter ablation for arrhythmia prevention is to be considered in case of clinical suggestions that AF is initiated by a primary regular arrhythmia that is amenable to routine catheter ablation (secondary AF). Despite encouraging results, at this point in time, curative catheter ablation for primary AF may offer significant improvement or even cure only for a small subset of patients, mostly young individuals with normal heart, and paroxysmal AF with frequent, symptomatic episodes refractory to multiple antiarrhythmic drugs. These interventions are to be performed in the settings of a clinical research project in some institutions. Regarding pacemaker therapy in case of bradycardia indication, physiologic pacing (AAI or DDD) is associated with significantly lower incidence of atrial fibrillation than ventricular pacing. Large-scale randomized controlled trials are needed to assess the clinical value of specially designed implantable devices to prevent atrial fibrillation in patients with no conventional bradycardia indication. Also, technical optimization and proper clinical evaluation is needed for implantable atrioverters and implantable cardioverter defibrillators capable of atrial cardioversion therapy.

UR - http://www.scopus.com/inward/record.url?scp=0141789650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141789650&partnerID=8YFLogxK

M3 - Article

C2 - 12894672

AN - SCOPUS:0141789650

VL - 144

SP - 1279

EP - 1289

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 26

ER -